Buy Sulfargin ointment 50 g
  • Buy Sulfargin ointment 50 g

Sulfadiazine

Tallinn Pharmaceutical Plant
734 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$35.56
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Sulfargin® is a broad-spectrum antimicrobial bactericidal agent belonging to the group of sulfonamides. The drug is active against gram-positive and gram-negative bacteria Escherichia coli, Proteus spp., Staphylococcus spp., Klebsiella spp.

The bactericidal properties of Sulfargin ointment are due to the activity of silver ions, which are released in the wound as a result of the dissociation of the silver sulfadiazine salt; the release of silver ions occurs gradually (moderate dissociation), ensuring the constancy of the antimicrobial effect. The bactericidal activity of silver ions is complemented by the bacteriostatic effect of sulfadiazine (also released during the dissociation of the silver salt of sulfadiazine).

Sulfargin is characterized by moderate osmotic activity and does not possess necrolytic properties.

When applied to the wound surface, about 10% sulfadiazine and 1% silver are absorbed into the peripheral and systemic circulation. Application to the extensive wound surface is accompanied by an increase in the concentration of sulfadiazine in the blood to 10-20 μg / ml.

Indications

Treatment of infected burn wounds, pressure sores, abrasions, skin ulcers, transplanted skin; and the prevention of their infection.

Wounds (including nonhealing), trophic ulcers, bedsores, burns with mild exudation.

Composition

1 g ointment contains:
active substance: silver sulfadiazine 10 mg;
Excipients: vaseline oil, propylene glycol, cetyl stearyl alcohol, glycerol monostearate 40-55, polysorbate 80, methyl parahydroxybenzoate, propyl parahydroxybenzoate, purified water.

No customer reviews for the moment.

Write your review

Write your review

Sulfadiazine

Dosage and Administration

Outwardly. After surgical treatment of the wound and removal of necrotic tissue, a thin layer (2-4 mm) of ointment (under a bandage or open method) is applied to the damaged surface 1-2 times a day.
The maximum single dose is 300 g. The treatment period is individual and depends on the nature of the disease and the effectiveness of the treatment used, in general cases lasts up to 3 weeks.
Application of the ointment to the skin is painless, the ointment does not stain clothes and linen.
If you forget to use the drug, use it as soon as possible and continue using as usual Do not use a double dose if the previous time of drug administration was missed.
If you feel that the effect of the drug is too strong or weak, inform your doctor about it.

Adverse reactions

Burning and itching at the site of application, violation of skin pigmentation, skin allergic reactions, skin necrosis, erythema multiforme, interstitial nephritis, leukopenia, which is mainly characterized by a decrease in the number of neutrophils.
With prolonged use on large wound surfaces: systemic side effects characteristic of sulfonamide drugs, including impaired hematopoiesis (agranulocytosis, aplastic and hemolytic anemia, thrombocytopenia, leukopenia), skin and allergic reactions, including Stevens-Johnson syndrome and exfoliative dermatitis ; dyspepsia, hepatitis, hepatocellular necrosis, dysfunction of the central nervous system and toxic nephrosis.
The degree of absorption of the drug depends on the size of the burn surface and the degree of tissue damage.
  • Brand name: Sulfargin
  • Active ingredient: Sulfadiazine
  • Dosage form: Ointment for external use of 1%.
  • Manufacturer: Tallinn Pharmaceutical Plant
  • Country of Origin: Estonia

Studies and clinical trials of Sulfadiazine (Click to expand)

  1. Preparation of PEO with amine and sulfadiazine end groups by anion ring-opening polymerization of ethylene oxide
  2. Ring-opening polymerization of ethylene oxide by anion initiation using sulfadiazine as parents compound
  3. Antibacterial activity of chitosan–alginate sponges incorporating silver sulfadiazine: Effect of ladder-loop transition of interpolyelectrolyte complex and ionic crosslinking on the antibiotic release
  4. Mechanical properties and release studies of chitosan films impregnated with silver sulfadiazine
  5. Effect of the synthesis initiation mode on the structure and properties of sulfadiazine molecularly imprinted polymers
  6. Silver Succinylsulfadiazine and Silver Sulfadiazine Imidazole: Two New Derivatives of the Antibacterial Silver Sulfadiazine
  7. A silver-sulfadiazine-impregnated synthetic wound dressing composed of poly-l-leucine spongy matrix: An evaluation of clinical cases
  8. Efficiency of controlled topical delivery of silver sulfadiazine in infected burn wounds
  9. Design and delivery of silver sulfadiazine from alginate microspheres-impregnated collagen scaffold
  10. The oxidative degradation of sulfadiazine at the interface of α-MnO2 and water
  11. The survival of amblystoma embryos when treated with sodium sulfadiazine and quinine sulphate
  12. Synthèse de l'amino-2 pyrimidine 14C-2; de la N4-di (chloro-2 n-propyl) sulfadiazine (pyrimidine 14C-2) ou CB 1932 14C
  13. Synthese de la sulfadiazine et de ses derives : LA (N4 - acetylsulfani lamido) - -2 pyrimidine, la (bennzenesulfonamito) -2 pyrimidine et la (P - toluenesulfonamido) - 2 pyrimidine marquees par le 14C dans le noyau pyrimidine
  14. IPM/DOSS/water microemulsions as reactors for silver sulfadiazine nanocrystal synthesis
  15. Absorption and excretion of sulfadiazine after subcutaneous implantation of disks in rats
  16. Physiologic surface-active agents and drug absorption VIII: Effect of bile flow on sulfadiazine absorption in the rat
  17. Solubilities of sulfadiazine, sulfisomidine, and sulfadimethoxine in several normal alcohols
  18. Characterization of silver sulfadiazine and related compounds
  19. Effects of colestipol hydrochloride on drug absorption in the rat I: Aspirin, L-thyroxine, phenobarbital, cortisone, and sulfadiazine
  20. Spectrophotofluorometric analysis of procainamide and sulfadiazine in presence of primary aliphatic amines based on reaction with fluorescamine
  21. Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam
  22. Specific TLC tissue residue determination of sulfadiazine following fluorescamine derivatization
  23. Effect of dioctyl sodium sulfosuccinate and poloxamer 188 on dissolution and intestinal absorption of sulfadiazine and sulfisoxazole in rats
  24. Solubility studies of silver sulfadiazine

8 other products in the same category:

arrow_upward